Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases
Submission Deadline: 31 Dec 2018
Guest Editors
PhD;DSc., State University of New York, Downstate Medical Center, Department of Medicine, 450 Clarkson Ave, Brooklyn, New York 11203, USA
Interests: 33 publications, 1 grants, Editor of 8
PhD., Université de Lorraine, Faculté de Pharmacie, 5 rue Albert Lebrun, 54000, Nancy, France
Interests: 33 publications, 1 grants, Editor of 8
Keywords
- Cardiovascular System
- Cell Biology
- Diagnostics
- Genes and Genetics
- Inflammatory Responses
- Nutrition
- Molecular Biology
- Signaling
- Technology
- Therapeutics
Published Papers (12)
Diet-induced differential effects on plasma lipids secretion by the inositol-requiring transmembrane kinase/endoribonuclease 1
Front. Biosci. (Landmark Ed) 2021, 26(5), 11–21; https://doi.org/10.52586/4920
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Association between nitrated lipoproteins and vascular function in type 2 diabetes
Front. Biosci. (Landmark Ed) 2021, 26(4), 644–663; https://doi.org/10.2741/4910
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
High-density lipoprotein carbamylation and dysfunction in vascular disease
High-density lipoprotein carbamylation and dysfunction in vascular disease
Front. Biosci. (Landmark Ed) 2018, 23(12), 2227–2234; https://doi.org/10.2741/4701
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Epigenetic regulation of genes involved in the reverse cholesterol transport through interaction with miRNAs
Epigenetic regulation of genes involved in the reverse cholesterol transport through interaction with miRNAs
Front. Biosci. (Landmark Ed) 2018, 23(11), 2090–2105; https://doi.org/10.2741/4692
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Effects of oxidized lipids and lipoproteins on cardiac function
Effects of oxidized lipids and lipoproteins on cardiac function
Front. Biosci. (Landmark Ed) 2018, 23(10), 1822–1847; https://doi.org/10.2741/4675
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Modified lipoproteins as biomarkers of atherosclerosis
Modified lipoproteins as biomarkers of atherosclerosis
Front. Biosci. (Landmark Ed) 2018, 23(8), 1422–1444; https://doi.org/10.2741/4653
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
The “forgotten” modified lipoprotein subspecies
The “forgotten” modified lipoprotein subspecies
Front. Biosci. (Landmark Ed) 2018, 23(3), 458–463; https://doi.org/10.2741/4599
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease
Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease
Front. Biosci. (Landmark Ed) 2018, 23(1), 146–161; https://doi.org/10.2741/4585
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Enzymatically modified LDL, atherosclerosis and beyond: paving the way to acceptance
Enzymatically modified LDL, atherosclerosis and beyond: paving the way to acceptance
Front. Biosci. (Landmark Ed) 2018, 23(7), 1257–1271; https://doi.org/10.2741/4642
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Modified low-density lipoproteins as biomarkers in diabetes and metabolic syndrome
Modified low-density lipoproteins as biomarkers in diabetes and metabolic syndrome
Front. Biosci. (Landmark Ed) 2018, 23(7), 1220–1240; https://doi.org/10.2741/4640
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein
Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein
Front. Biosci. (Landmark Ed) 2018, 23(6), 1099–1112; https://doi.org/10.2741/4635
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)
Prenylcysteine oxidase 1, a pro-oxidant enzyme of low density lipoproteins
Prenylcysteine oxidase 1, a pro-oxidant enzyme of low density lipoproteins
Front. Biosci. (Landmark Ed) 2018, 23(6), 1020–1037; https://doi.org/10.2741/4631
(This article belongs to the Special Issue Modified lipoproteins as biomarkers of cardiovascular and metabolic diseases)